Carbon Dioxide Laser vs. Electrocoagulation for the Therapy of Condyloma

Status Recruiting

Clinical Trial Summary

In a randomized clinical trial of 114 women undergoing Treatment for condyloma acuminata, two surgical methods, the carbon dioxide laser Ablation and the excision by electrocoagulation, will be compared. The primary outcome of the study is the cosmetic result judged by the Patient 6 weeks after Treatment using a 11-step visual analogue scale (VAS), secondary outcomes are intervention time, operative complications, subjects and users satisfaction, postoperative pain and recurrence of genital warts.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Condylomata Acuminata

Clinical Trial Details

NCT number	NCT02520986
Study type	Interventional
Source	Zydolab - Institute of Cytology and Immune Cytochemistry
Contact	Ziad Hilal, Dr. med.
Phone	+49231529747
Email	z.hilal@zydolab.de
Status	Recruiting
Phase	N/A
Start date	December 2016
Completion date	December 2024

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04537156` - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 3
Completed	`NCT00090285` - An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)	Phase 3
Completed	`NCT00973856` - Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands	N/A
Completed	`NCT02015260` - A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts	Phase 2
Active, not recruiting	`NCT05056402` - An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old	Phase 3
Withdrawn	`NCT00365443` - Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)	Phase 2
Not yet recruiting	`NCT01483794` - Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile	N/A
Completed	`NCT03935204` - Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 2
Completed	`NCT02405520` - Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine	Phase 1
Active, not recruiting	`NCT02710851` - Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine	Phase 2
Completed	`NCT04782895` - Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age	Phase 3
Completed	`NCT03546842` - Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)	Phase 3
Completed	`NCT03981822` - A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts	Phase 2
Recruiting	`NCT03158480` - Safety and Efficacy of Immune Therapy for Condyloma	N/A
Completed	`NCT01598779` - Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population	N/A
Not yet recruiting	`NCT06430190` - Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata	N/A
Completed	`NCT00449982` - Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts	Phase 3
Completed	`NCT03813940` - Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 1
Not yet recruiting	`NCT06197802` - Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women
Completed	`NCT01532102` - Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts	Phase 1/Phase 2